<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251006067516N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-12-09</date_registration>
      <primary_sponsor>The University of  modares</primary_sponsor>
      <public_title>Effect of resistance training with and without transcranial direct current stimulation  on upper limb recovery after stroke</public_title>
      <acronym>transcranial direct current stimulation(tDCS)</acronym>
      <scientific_title>Investigation the effectiveness of adding transcranial direct current stimulation to resistance exercise on function, quality of life, and movement smoothness of the upper limbs in individuals with stroke</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-12-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/86655</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: After becoming aware of the aims and steps of the plan, participants will read and sign the consent form.
The randomization method in this trial is simple randomization.
Upon entry into the study, participants will be divided into two groups—resistance training and resistance training combined with tDCS—using sealed, opaque envelopes, Blinding description: During the tDCS procedure, some patients may not feel any sensation, but the stimulation is still applied. As a result, the patient does not know which group they are assigned to.
The tDCS is administered by a different clinician, and the clinician is blinded to group assignment (they do not know which treatment the patient receives).
Additionally, the analyst who processes the data is blinded to the groupings (the grouping is masked from them as well).
Therefore, this study is double-blinded (or double-masked): both the clinician delivering the treatment and the person analyzing the data do not know the group assignments.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Upper limb of patients with stroke.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention A-tDCS Initially, for 20 minutes, this protocol is applied to patients assigned to this group. Considering that previous studies have reported  tDCS after-effects persisting up to 1.5 hours post-stimulation, conventional resistance training is performed after the stimulation period according to the intervention of the first group. The tDCS execution protocol is as follows: Neutral (reference) electrode: the midpoint of the forehead Active electrode: placed over points C3 and C4 according to the standard 10-20 EEG system Electrode size: 35 cm² (5 cm × 7 cm)Current intensity: 1 mA Stimulation duration: 20 minutes Number of treatment sessions: 6 weeks, every other day Device model: Segal Stim two-channel Pharmaceutical Medical Equipment Company FarmedBefore starting treatment, the electrode pads are moistened with normal saline solution, and the treatment area is cleaned with an alcohol pad to remove fat. Then the hair is moved aside as much as possible and the electrodes are fixed to the scalp and forehead using straps. The current intensity is set to 1 mA, and the patient is instructed to report any uncomfortable sensations such as burning as soon as they occur. If such sensations arise, the therapist reduces the current intensity until the patient again feels comfortable. All of these procedures are recorded. Intervention 2: Before the main intervention for both groups, participants perform a 10-minute warm-up. First, each joint is actively moved ten times through its maximum possible range of motion. After the active exercises, for the shorter muscles, a passive stretch is performed for three sets of 45 seconds. The stretches are performed so that the limb is placed at the target maximum range of motion in the resistance training that is not painful for the patient. In other words, the stretch corresponds to the maximum pain-free range for the spastic muscles. During stretching, the joints of the fingers and wrist are kept in a neutral position with a splint.In the resistance-training group, stroke patients perform movements using a calf weight and a pulley resistance system to flexion, abduction, external rotation, horizontal abduction and adduction of the shoulder, as well as flexion and extension of the elbow. To determine 1RM, the patient first performs the maximum range of motion. Then the patient starts with a weight that they believe they can lift with maximal effort for one repetition. The weight is then increased until the maximum load they can lift for one full range of motion is reached. If the participant cannot complete one repetition, 2.5% of the weight used in the test is reduced. The exercises are performed at 80% of 1RM. When the patient can perform 12 repetitions, the weight is increased so that 8 repetitions can be performed. Each exercise is performed in three sets of 8 repetitions.Before the main intervention for both groups, participants perform a 10-minute warm-up. First, each joint is actively moved ten times through its maximum possible range of motion. After the active exercises, for the shorter muscles, a passive stretch is performed for three sets of 45 seconds. The stretches are performed so that the limb is at the maximum pain-free range targeted in the resistance training that is not painful for the patient. The joints of the fingers and wrist are kept in a neutral position with a splint during stretching. In the resistance-training group, stroke patients perform movements with a calf weight and a pulley resistance system to move flexion, abduction, external rotation, horizontal abduction and adduction of the shoulder, and flexion and extension of the elbow. To determine 1RM, the patient first performs the maximum range of motion. Then the patient starts with a weight they believe they can lift with maximal effort for one repetition. The weight is increased until the maximum load that can be lifted for one full range of motion is reached. If the participant cannot perform one repetition, 2.5% of the load used in the test is subtracted. The training is performed at 80% of 1RM. When the patient can perform 12 repetitions, the weight is increased to perform 8 repetitions. Each exercise is performed as three sets of 8 repetitions.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information related to the results of the assessment of main outcomes will be published in the article and thesis.
Access to the microdata will be allowed only with approval from the supervisors and on a restricted basis for the target journal, after de-identification, and in a resolvable Excel format.

When:
After the sampling is completed, in the article and thesis.

To whom:
All individuals with access to the thesis and article registry will have access to the study results. More detailed data will be available to the journal with the approval of the supervisors and on a restricted basis.

Conditions:
Documented data may be used for review articles and clinical decision-making, and the granular details will be available only in a limited manner, with supervisor approval, to ensure the validity of the results for the target journal upon request.

Where to obtain:
dpttehran@gmail.com
09377525456

How to obtain:
Initial contact will be made through the available communication channels. The request will be submitted to the supervisors. Any questions from the supervisors will be addressed to the individual, and, if approved, the information will be provided to the individual on a restricted basis.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mehrdad Sadeghnia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 30, Shahrivar Ave., Keshavarz Blvd</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411956511</zip>
        <telephone>+98 21 8288 2009</telephone>
        <email>dpttehran@gmail.com</email>
        <affiliation>The University of Modares</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mehrdad Sadeghnia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 30, Shahrivar Ave., Keshavarz Blvd</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411956511</zip>
        <telephone>+98 21 8288 2009</telephone>
        <email>dpttehran@gmail.com</email>
        <affiliation>The University of Modares</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Ischemic hemiplegia
Stroke in the territory of the middle cerebral artery
At least three months since the event
Fugl-Meyer Assessment upper-extremity score between 18 and 48
Shoulder pain with a Visual Analog Scale (VAS) score less than 3
Modified Ashworth Scale score for the biceps muscle of 2
No cognitive or perceptual impairments that would hinder following the treatment process (MMSE score at least 18)
Written informed consent form confirmed for participation in the study</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Complex Regional Pain Syndrome
Patients with depression who are unable to participate in treatment
Cardiovascular problems
Other problems in neurology, orthopedics, and rheumatology
Presence of severe comorbidities
Presence of contracture</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention A-tDCS Initially, for 20 minutes, this protocol is applied to patients assigned to this group. Considering that previous studies have reported  tDCS after-effects persisting up to 1.5 hours post-stimulation, conventional resistance training is performed after the stimulation period according to the intervention of the first group. The tDCS execution protocol is as follows: Neutral (reference) electrode: the midpoint of the forehead Active electrode: placed over points C3 and C4 according to the standard 10-20 EEG system Electrode size: 35 cm² (5 cm × 7 cm)Current intensity: 1 mA Stimulation duration: 20 minutes Number of treatment sessions: 6 weeks, every other day Device model: Segal Stim two-channel Pharmaceutical Medical Equipment Company FarmedBefore starting treatment, the electrode pads are moistened with normal saline solution, and the treatment area is cleaned with an alcohol pad to remove fat. Then the hair is moved aside as much as possible and the electrodes are fixed to the scalp and forehead using straps. The current intensity is set to 1 mA, and the patient is instructed to report any uncomfortable sensations such as burning as soon as they occur. If such sensations arise, the therapist reduces the current intensity until the patient again feels comfortable. All of these procedures are recorded.</i_keyword>
      <i_keyword>Before the main intervention for both groups, participants perform a 10-minute warm-up. First, each joint is actively moved ten times through its maximum possible range of motion. After the active exercises, for the shorter muscles, a passive stretch is performed for three sets of 45 seconds. The stretches are performed so that the limb is placed at the target maximum range of motion in the resistance training that is not painful for the patient. In other words, the stretch corresponds to the maximum pain-free range for the spastic muscles. During stretching, the joints of the fingers and wrist are kept in a neutral position with a splint.In the resistance-training group, stroke patients perform movements using a calf weight and a pulley resistance system to flexion, abduction, external rotation, horizontal abduction and adduction of the shoulder, as well as flexion and extension of the elbow. To determine 1RM, the patient first performs the maximum range of motion. Then the patient starts with a weight that they believe they can lift with maximal effort for one repetition. The weight is then increased until the maximum load they can lift for one full range of motion is reached. If the participant cannot complete one repetition, 2.5% of the weight used in the test is reduced. The exercises are performed at 80% of 1RM. When the patient can perform 12 repetitions, the weight is increased so that 8 repetitions can be performed. Each exercise is performed in three sets of 8 repetitions.Before the main intervention for both groups, participants perform a 10-minute warm-up. First, each joint is actively moved ten times through its maximum possible range of motion. After the active exercises, for the shorter muscles, a passive stretch is performed for three sets of 45 seconds. The stretches are performed so that the limb is at the maximum pain-free range targeted in the resistance training that is not painful for the patient. The joints of the fingers and wrist are kept in a neutral position with a splint during stretching. In the resistance-training group, stroke patients perform movements with a calf weight and a pulley resistance system to move flexion, abduction, external rotation, horizontal abduction and adduction of the shoulder, and flexion and extension of the elbow. To determine 1RM, the patient first performs the maximum range of motion. Then the patient starts with a weight they believe they can lift with maximal effort for one repetition. The weight is increased until the maximum load that can be lifted for one full range of motion is reached. If the participant cannot perform one repetition, 2.5% of the load used in the test is subtracted. The training is performed at 80% of 1RM. When the patient can perform 12 repetitions, the weight is increased to perform 8 repetitions. Each exercise is performed as three sets of 8 repetitions.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fugl-Meyer Assessment. Timepoint: Before and after six weeks of treatment. Method of measurement: Thirty-three items pertain to the upper limb, including the shoulder, elbow, forearm, and wrist. The test is scored based on direct observation of performance, with each item scored from 0 to 2. If a person cannot perform the movement, the score is 0; if the movement is performed partially, the score is 1; if the movement is performed fully, the score is 2.</prim_outcome>
      <prim_outcome>Modified Ashworth Scale: It is a ranked scale for measuring spasticity. Timepoint: Before and after six weeks of treatment. Method of measurement: t is rated on a scale from zero to four. Grade 2 indicates a clear increase in muscle tone that is evident when the joint is held in a specified range, but the limb(s) can be moved easily.</prim_outcome>
      <prim_outcome>Maximum muscular power: For measuring the strength (in kilograms) of the muscles of the upper limb, including flexors, extensors, abductors, adductors, internal and external rotators of the shoulder, flexors and extensors of the elbow, using a nerve stimulator (Lafayette Company. Timepoint: Before and after six weeks of treatment. Method of measurement: Each test will be performed three times: once by the examiner for training, once by the patient to learn how to perform it, and once again by the patient to perform it. Muscle power measurements for two directions, flexion and abduction, will be carried out once in the lower position and once in the upper position using a nerve stimulator (Lafayette Company).</prim_outcome>
      <prim_outcome>Maximum range of motion for shoulder flexion and abduction. Timepoint: Before and after six weeks of treatment. Method of measurement: For measuring the range of motion (ROM) of shoulder abduction, the patient sits on a chair and the examiner holds the fixed arm of the goniometer completely perpendicular to the trunk in the frontal plane, with the goniometer's axis centered on the acromion process. The movable arm of the goniometer follows the arm and runs along the lateral epicondyle of the elbow, parallel to the arm, as the shoulder moves toward abduction. To measure shoulder flexion, the goniometer's axis is placed 2.5 cm proximal to the acromion on the outer aspect of the shoulder, with the fixed arm in the midline of the trunk, the upper chest, and the movable arm along the lateral midline of the arm in line with the external epicondyle. The distance between the two arms is recorded as the ROM for shoulder flexion.</prim_outcome>
      <prim_outcome>Kinematic analysis for assessing the functional movement of the involved hand and also calculating movement smoothness. Timepoint: Before and after six weeks of treatment. Method of measurement: Marker placement will be on the radial groove of the radial/radius? (the radioulnar area seems intended: radial styloid, radius radial styloid and medial radial styloid) and the motion analysis device (VICON, ) will record data at 120 Hz. The output of the kinetic model will be the sum of the movement of the upper limb when reaching an object in both the upward and downward directions in two motions: flexion and abduction. Movement smoothness will be based on the SPARC variable during four reaching movements, calculated from the arc length of the velocity signal spectrum (V).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The University of  modares</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-04-25</approval_date>
        <contact_name>Ethics committee of Modares University</contact_name>
        <contact_address>No. 30, Shahrivar Ave., North Kargar Blvd Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
